Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype
Karen K. McKee, … , Markus A. Rüegg, Peter D. Yurchenco
Karen K. McKee, … , Markus A. Rüegg, Peter D. Yurchenco
Published February 20, 2017
Citation Information: J Clin Invest. 2017;127(3):1075-1089. https://doi.org/10.1172/JCI90854.
View: Text | PDF
Research Article Muscle biology Article has an altmetric score of 23

Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype

  • Text
  • PDF
Abstract

Mutations in laminin α2-subunit (Lmα2, encoded by LAMA2) are linked to approximately 30% of congenital muscular dystrophy cases. Mice with a homozygous mutation in Lama2 (dy2J mice) express a nonpolymerizing form of laminin-211 (Lm211) and are a model for ambulatory-type Lmα2-deficient muscular dystrophy. Here, we developed transgenic dy2J mice with muscle-specific expression of αLNNd, a laminin/nidogen chimeric protein that provides a missing polymerization domain. Muscle-specific expression of αLNNd in dy2J mice resulted in strong amelioration of the dystrophic phenotype, manifested by the prevention of fibrosis and restoration of forelimb grip strength. αLNNd also restored myofiber shape, size, and numbers to control levels in dy2J mice. Laminin immunostaining and quantitation of tissue extractions revealed increased Lm211 expression in αLNNd-transgenic dy2J mice. In cultured myotubes, we determined that αLNNd expression increased myotube surface accumulation of polymerization-deficient recombinant laminins, with retention of collagen IV, reiterating the basement membrane (BM) changes observed in vivo. Laminin LN domain mutations linked to several of the Lmα2-deficient muscular dystrophies are predicted to compromise polymerization. The data herein support the hypothesis that engineered expression of αLNNd can overcome polymerization deficits to increase laminin, stabilize BM structure, and substantially ameliorate muscular dystrophy.

Authors

Karen K. McKee, Stephanie C. Crosson, Sarina Meinen, Judith R. Reinhard, Markus A. Rüegg, Peter D. Yurchenco

×

Figure 6

αLNNd and nidogen-1 in muscle.

Options: View larger image (or click on image) Download as PowerPoint
αLNNd and nidogen-1 in muscle.
(A) Combined extracts (B plus C plus E) f...
(A) Combined extracts (B plus C plus E) from 4-week-old forelimb dy2J and Tg+dy2J muscle were immunoprecipitated twice with αLNNd-specific Ab (anti-F2, IP #1 and IP #2). The αLNNd-depleted supernatants were then immunoprecipitated with anti-nidogen G2-G3 (IP #3 and IP #4). Precipitates, following SDS-PAGE and membrane transfer, were immunoblotted with anti-Lmβ1γ1 (upper cut membrane, dotted cut line shown) and anti-nidogen G2-G3 (lower cut membrane). αLNNd was detected only in the Tg+dy2J muscle. (While a small amount of nidogen was present in the anti-F2 immunoprecipitates of the dy2J control muscle, this band was similarly seen in immunoblots precipitated with anti-IgY agarose beads alone and deduced to result from nonspecific nidogen binding to beads). Following αLNNd depletion, isolated nidogen was immunoprecipitated with anti–nidogen G2-G3 Ab. The upper αLNNd band was distinguished from the adjacent nidogen band to determine the relative amounts in the lysates (IP #1 plus IP #2). To estimate the fraction of β1γ1-laminins bound to αLNNd and to nidogen-1, the laminin band intensities were multiplied by the fraction of αLNNd and nidogen-1 in each blot to determine the distribution and then summed. (B) Plot (average ± SD, n = 4 mice/condition, P = 0.007, by 2-tailed t test) of the calculated fraction of αLNNd relative to the total of αLNNd plus nidogen and the fraction of β1γ1 laminins bound to αLNNd relative to total β1γ1 laminins. Lm, laminins.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 20 X users
Referenced in 6 patents
On 1 Facebook pages
54 readers on Mendeley
See more details